Update on the core and developing cerebrospinal fluid biomarkers for Alzheimer disease

Alzheimer disease (AD) is a complex neurodegenerative disorder, whose prevalence will dramatically rise by 2050. Despite numerous clinical trials investigating this disease, there is still no effective treatment. Many trials showed negative or inconclusive results, possibly because they recruited on...

Descripción completa

Detalles Bibliográficos
Autores principales: Babić, Mirjana, Švob Štrac, Dubravka, Mück-Šeler, Dorotea, Pivac, Nela, Stanić, Gabrijela, Hof, Patrick R., Šimić, Goran
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Croatian Medical Schools 2014
Materias:
Cerebrospinal Fluid Physiology and Movement
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4157375/
https://www.ncbi.nlm.nih.gov/pubmed/25165049
http://dx.doi.org/10.3325/cmj.2014.55.347

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4157375/
https://www.ncbi.nlm.nih.gov/pubmed/25165049
http://dx.doi.org/10.3325/cmj.2014.55.347

Ejemplares similares